More Syntara Limited news Syntara LimitedASX: SNT Presentation: Phase 2 study of SNT-5505 in myelofibrosis Dec 10, 2024 at 6:52 AM UTC · Issued by Syntara Limited As issuedPlain English Syntara Limited has released a press release. View Attachment
